Interestingly, the increases in the levels of the serum K18 biomarkers – and in particular ccK18 (the M30 ELISA analyte) - were clearly larger than the increases in tumor binding potential for [11C]-AnxA5-ST. The gene discussed is KRT18; the disease is neoplasm.